Legacy Wealth Management (Idaho)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27K Buy
+21
New +$1.22K ﹤0.01% 836
2025
Q3
Sell
-30
Closed -$1.39K 783
2025
Q2
$1.39K Sell
30
-175
-85% -$8.59K ﹤0.01% 560
2025
Q1
$12.5K Buy
205
+175
+583% +$10.2K 0.01% 299
2024
Q4
$1.71K Hold
30
﹤0.01% 520
2024
Q3
$1.75K Buy
+30
New +$1.41K ﹤0.01% 494

Other funds holding BMY

Legacy Wealth Management (Idaho)'s BMY Position: Q1 2026 in Review

Legacy Wealth Management (Idaho) opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 21 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: Legacy Wealth Management (Idaho) previously reported a position in BMY as recently as Q2 2025.

Legacy Wealth Management (Idaho) first reported a position in BMY in Q3 2024 and has held it in 5 quarters since. The position peaked at $12.5K in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Legacy Wealth Management (Idaho) held 21 shares of Bristol-Myers Squibb worth $1.27K as of Q1 2026.
  • Bristol-Myers Squibb was a new Legacy Wealth Management (Idaho) position in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #836 holding.
  • Legacy Wealth Management (Idaho) first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 5 quarters since.
  • Legacy Wealth Management (Idaho)'s Bristol-Myers Squibb position peaked at $12.5K in Q1 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.